REGN

#254
Regeneron Pharmaceuticals, Inc. - Common Stock
619.4 2 USD
-0.34%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
617.80
624.47
Faixa anual
476.48
821.11
Mudança diária
-0.34%
Mudança mensal
-10.63%
Mudança em 6 meses
-20.17%
Mudança anual
+20.04%
Fechamento anterior
621.5 2
Open
620.1 1
Mínimo
617.8 0
High
624.4 7
Volume
685
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 64.94 B
  • Employee 15 K
  • Founded 1988
  • CEO Leonard Schleifer
  • Website www.regeneron.com
  • Headquarter New York, United States
  • FIGI BBG000C734W3
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
18.61
Índice preço/fluxo de caixa
5.84

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Notícias